PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.02%
Revenue growth under 50% of AVGO's 11.10%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
5.17%
Gross profit growth under 50% of AVGO's 13.00%. Michael Burry would be concerned about a severe competitive disadvantage.
6.80%
EBIT growth below 50% of AVGO's 51.39%. Michael Burry would suspect deeper competitive or cost structure issues.
6.80%
Operating income growth under 50% of AVGO's 51.39%. Michael Burry would be concerned about deeper cost or sales issues.
5.67%
Net income growth under 50% of AVGO's 92.44%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.41%
EPS growth under 50% of AVGO's 106.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.56%
Diluted EPS growth under 50% of AVGO's 107.14%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.33%
Share reduction more than 1.5x AVGO's 0.75%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.49%
Diluted share reduction more than 1.5x AVGO's 1.20%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.70%
Maintaining or increasing dividends while AVGO cut them. John Neff might see a strong edge in shareholder returns.
-10.67%
Negative OCF growth while AVGO is at 5.35%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-14.05%
Negative FCF growth while AVGO is at 5.63%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
188.19%
10Y revenue/share CAGR under 50% of AVGO's 573.88%. Michael Burry would suspect a lasting competitive disadvantage.
120.78%
5Y revenue/share CAGR at 75-90% of AVGO's 138.92%. Bill Ackman would encourage strategies to match competitor’s pace.
29.11%
3Y revenue/share CAGR at 75-90% of AVGO's 34.16%. Bill Ackman would expect new product strategies to close the gap.
1829.29%
10Y OCF/share CAGR above 1.5x AVGO's 819.60%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
194.23%
5Y OCF/share CAGR at 50-75% of AVGO's 291.05%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
83.60%
3Y OCF/share CAGR 1.25-1.5x AVGO's 71.74%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
560.92%
Net income/share CAGR 1.25-1.5x AVGO's 381.19%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
337.38%
5Y net income/share CAGR above 1.5x AVGO's 109.80%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
31.06%
Below 50% of AVGO's 109.19%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
317.57%
Below 50% of AVGO's 846.57%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
145.62%
5Y equity/share CAGR at 50-75% of AVGO's 244.66%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
91.38%
3Y equity/share CAGR above 1.5x AVGO's 17.80%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
88.54%
Below 50% of AVGO's 717.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
16.52%
Below 50% of AVGO's 236.98%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
13.88%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-6.49%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
9.52%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
8.47%
BV/share growth above 1.5x AVGO's 0.59%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.16%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
3.65%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.61%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.